X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2020/06/05/2044238/0/en/Menlo-Therapeutics-Announces-Pricing-of-Offering-of-Common-Stock.html
https://www.globenewswire.com/news-release/2020/06/02/2042185/0/en/Menlo-Therapeutics-Announces-Positive-Results-from-Phase-2-Trial-of-FCD105-for-the-Treatment-of-Moderate-to-Severe-Acne-Vulgaris.html
https://www.prnewswire.com/news-releases/menlo-therapeutics-receives-fda-approval-of-zilxi-minocycline-topical-foam-1-5-the-first-topical-minocycline-treatment-for-rosacea-301067795.html
https://www.globenewswire.com/news-release/2020/05/27/2039354/0/en/Menlo-Therapeutics-Announces-Covered-Status-for-AMZEEQ-minocycline-topical-foam-4-on-Additional-Commercial-Formulary.html
https://www.globenewswire.com/news-release/2020/04/23/2020865/0/en/Menlo-Therapeutics-and-Cutia-Therapeutics-Enter-into-Exclusive-License-Agreement-for-AMZEEQ-and-Approved-Topical-Minocycline-Products-in-Greater-China.html
http://www.pharmatimes.com/news/menlo_hit_with_serlopitant_setback_1337850
https://endpts.com/a-pair-of-phiii-failures-spells-last-rites-for-menlos-once-promising-merck-drug/
https://www.prnewswire.com/news-releases/menlo-therapeutics-and-foamix-pharmaceuticals-complete-merger-creating-a-combined-company-focused-on-the-development-and-commercialization-of-therapeutics-for-dermatologic-indications-301019699.html
https://www.globenewswire.com/news-release/2020/02/26/1990868/0/en/Menlo-Therapeutics-Announces-Results-from-Phase-2-Trial-of-Serlopitant-in-Patients-with-Chronic-Pruritus-of-Unknown-Origin.html
Market Place
Share 
